ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1646

Cardiovascular disease in Systemic Lupus Erythematosus. The road to hell is paved with good intentions

Sophie Mavrogeni1 and Loukia Koutsogeorgopoulou2, 1CMR Department, Onassis Cardiac Surgery Center, Athens, Greece, 2Department of Pathophysiology, Rheumatology Unit, National Kapodistrian University of Athens, Athens, Greece

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Accurate diagnosis of cardiovascular involvement in systemic lupus erythematosus (SLE) remains challenging, because echocardiography (echo), the cornerstone tool used, has serious limitations. We hypothesized that cardiovascular magnetic resonance (CMR) detects cardiac lesions in SLE patients, missed by echo.

Methods: Between 2005-2015, eighty asymptomatic SLE patients, aged 37±6 yrs, 72F/8M with normal echo, under treatment with antimalarials, have been evaluated using a 1.5 T system. LV-RV ejection fraction, T2 ratio (oedema imaging) and late gadolinium enhancement (LGE) (fibrosis imaging) were assessed. Acute and chronic lesions were characterised as LGE-positive plus T2>2 or T2<2, respectively. According to LGE, lesions were characterized as: a) diffuse subendocardial, b) subepicardial and c) subendocardial /transmural, due to vasculitis, myocarditis and myocardial infarction, respectively

Results: Abnormal CMR findings were identified in 22/80 (27.5 %) asymptomatic SLE patients with normal echo, including 4/22 with recent onset of silent myocarditis, 9/22 with past myocardial infarction (6 inferior and 3 anterior subendocardial infarction), 5/22 with past myocarditis (subepicardial scar in inferolateral wall) and 4/22 with diffuse subendocardial fibrosis (DSF), due to vasculitis. No correlation between CMR findings and inflammatory indices was identified.

Conclusion: CMR in asymptomatic SLEs with normal echo can assess occult cardiac lesions including vasculitis, myocarditis and myocardial infarction, missed by echo that can influence both rheumatic and cardiac treatment and further risk stratification; therefore, it should be included in the diagnostic algorithm of SLE.


Disclosure: S. Mavrogeni, None; L. Koutsogeorgopoulou, None.

To cite this abstract in AMA style:

Mavrogeni S, Koutsogeorgopoulou L. Cardiovascular disease in Systemic Lupus Erythematosus. The road to hell is paved with good intentions [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-disease-in-systemic-lupus-erythematosus-the-road-to-hell-is-paved-with-good-intentions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-disease-in-systemic-lupus-erythematosus-the-road-to-hell-is-paved-with-good-intentions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology